The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the vaccine maker said on Friday.
Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision CAMBRIDGE, MA / ACCESS Newswire / July 25, 2025 / M
In the latest trading session, Moderna (MRNA) closed at $34.01, marking a -1.9% move from the previous day.

What's Going On With Moderna Stock Wednesday?

03:14pm, Wednesday, 23'rd Jul 2025
Moderna Inc.'s MRNA stock has surged approximately 37% in the last month but has dipped around 15% year to date.
The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments.
In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Moderna said on Friday it is cancelling plans to build a messenger RNA manufacturing plant in Japan due to "changes in the business environment" around the world and in Japan.

Moderna: Ready For The Redemption Arc

08:00am, Tuesday, 15'th Jul 2025
Moderna's stock has faced heavy pressure from negative headlines, regulatory setbacks, and political uncertainty, but recent FDA approvals have stabilized sentiment. The company now boasts three appro
It's difficult to get motivated about buying a stock that's plummeted or a company that seems to be out of favor with the general investment community. But if that company has bright long-term prospec
The latest trading day saw Moderna (MRNA) settling at $33.64, representing a -1.87% change from its previous close.
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to 11 years.
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than three years ago.
CAMBRIDGE, MA / ACCESS Newswire / July 11, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, August 1, 2025 to report i
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE